Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Rusert

Showing results (1-10 of 43) with videos related to

Pageof 5
Sort By:
The Journal of General Virology|June 7, 2022
Systematic HIV-1 promoter targeting with CRISPR/dCas9-VPR reveals optimal region for activation of the latent provirusSarah Klinnert, Alex Chemnitzer, Peter Rusert, et al.
Journal of Virology|November 21, 2008
Estimating the stoichiometry of human immunodeficiency virus entryCarsten Magnus, Peter Rusert, Sebastian Bonhoeffer, et al.
Frontiers in Immunology|September 12, 2022
Transcriptome profiles of latently- and reactivated HIV-1 infected primary CD4<sup>+</sup> T cells: A pooled data-analysisAnne Inderbitzin, Tom Loosli, Lennart Opitz, et al.
Chemical Communications (Cambridge, England)|September 11, 2010
Peptidomimetic inhibitors targeting the CCR5-binding site on the human immunodeficiency virus type-1 gp120 glycoprotein complexed to CD4Markus Seitz, Peter Rusert, Kerstin Moehle, et al.
Plos Pathogens|January 9, 2015
Different infectivity of HIV-1 strains is linked to number of envelope trimers required for entryOliver F Brandenberg, Carsten Magnus, Peter Rusert, et al.
Journal of Immunological Methods|September 18, 2013
Mathematical models: a key to understanding HIV envelope interactions?Carsten Magnus, Oliver F Brandenberg, Peter Rusert, et al.
Chembiochem : a European Journal of Chemical Biology|November 15, 2011
Synthetic virus-like particles and conformationally constrained peptidomimetics in vaccine designTina Riedel, Arin Ghasparian, Kerstin Moehle, et al.
AIDS (London, England)|July 7, 2009
Divergent effects of cell environment on HIV entry inhibitor activityPeter Rusert, Axel Mann, Michael Huber, et al.
Plos Pathogens|July 10, 2015
Capacity of Broadly Neutralizing Antibodies to Inhibit HIV-1 Cell-Cell Transmission Is Strain- and Epitope-DependentLucia Reh, Carsten Magnus, Merle Schanz, et al.
AIDS (London, England)|July 8, 2009
HIV sensitivity to neutralization is determined by target and virus producer cell propertiesAxel M Mann, Peter Rusert, Livia Berlinger, et al.
Pageof 5

Showing results (1-10 of 43) with videos related to

Sort By:
Pageof 5
The Journal of General Virology|June 7, 2022
Systematic HIV-1 promoter targeting with CRISPR/dCas9-VPR reveals optimal region for activation of the latent provirusSarah Klinnert, Alex Chemnitzer, Peter Rusert, et al.
Journal of Virology|November 21, 2008
Estimating the stoichiometry of human immunodeficiency virus entryCarsten Magnus, Peter Rusert, Sebastian Bonhoeffer, et al.
Frontiers in Immunology|September 12, 2022
Transcriptome profiles of latently- and reactivated HIV-1 infected primary CD4<sup>+</sup> T cells: A pooled data-analysisAnne Inderbitzin, Tom Loosli, Lennart Opitz, et al.
Chemical Communications (Cambridge, England)|September 11, 2010
Peptidomimetic inhibitors targeting the CCR5-binding site on the human immunodeficiency virus type-1 gp120 glycoprotein complexed to CD4Markus Seitz, Peter Rusert, Kerstin Moehle, et al.
Plos Pathogens|January 9, 2015
Different infectivity of HIV-1 strains is linked to number of envelope trimers required for entryOliver F Brandenberg, Carsten Magnus, Peter Rusert, et al.
Journal of Immunological Methods|September 18, 2013
Mathematical models: a key to understanding HIV envelope interactions?Carsten Magnus, Oliver F Brandenberg, Peter Rusert, et al.
Chembiochem : a European Journal of Chemical Biology|November 15, 2011
Synthetic virus-like particles and conformationally constrained peptidomimetics in vaccine designTina Riedel, Arin Ghasparian, Kerstin Moehle, et al.
AIDS (London, England)|July 7, 2009
Divergent effects of cell environment on HIV entry inhibitor activityPeter Rusert, Axel Mann, Michael Huber, et al.
Plos Pathogens|July 10, 2015
Capacity of Broadly Neutralizing Antibodies to Inhibit HIV-1 Cell-Cell Transmission Is Strain- and Epitope-DependentLucia Reh, Carsten Magnus, Merle Schanz, et al.
AIDS (London, England)|July 8, 2009
HIV sensitivity to neutralization is determined by target and virus producer cell propertiesAxel M Mann, Peter Rusert, Livia Berlinger, et al.
Pageof 5